Chris Nolet - Net Worth and Insider Trading

Chris Nolet Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chris Nolet owns 4 companies in total, including Viela Bio Inc (VIE) , Revance Therapeutics Inc (RVNC) , and Regenetp Inc (RGTPQ) among others .

Click here to see the complete history of Chris Nolet’s form 4 insider trades.

Insider Ownership Summary of Chris Nolet

Ticker	Comapny	Transaction Date	Type of Owner
VIE	Viela Bio Inc	2020-06-19	director
RVNC	Revance Therapeutics Inc	2019-07-16	director
RGTPQ	Regenetp Inc	2020-04-06	director
		2021-09-24	director

Chris Nolet Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chris Nolet Ownership Network

Ownership Network List of Chris Nolet

No Data

Ownership Network Relation of Chris Nolet

Chris Nolet Owned Company Details

What does Viela Bio Inc do?

Who are the key executives at Viela Bio Inc?

Chris Nolet is the director of Viela Bio Inc. Other key executives at Viela Bio Inc include 10 percent owner Boyu Capital General Partner III, Ltd. , 10 percent owner Boyu Capital Group Holdings Ltd. , and 10 percent owner Boyu Capital Investment Management Ltd .

Viela Bio Inc (VIE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Viela Bio Inc (VIE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viela Bio Inc (VIE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viela Bio Inc (VIE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viela Bio Inc Insider Transactions

No Available Data

What does Revance Therapeutics Inc do?

Who are the key executives at Revance Therapeutics Inc?

Chris Nolet is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .

Revance Therapeutics Inc (RVNC) Insider Trades Summary

Over the past 18 months, Chris Nolet made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .

In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.

Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revance Therapeutics Inc Insider Transactions

No Available Data

What does Regenetp Inc do?

Who are the key executives at Regenetp Inc?

Chris Nolet is the director of Regenetp Inc. Other key executives at Regenetp Inc include Chief Operating Officer Richard Hague , other: General Counsel Cameron J. Hoyler , and Chief Financial Officer Jacob Alexander Patterson .

Regenetp Inc (RGTPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regenetp Inc (RGTPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenetp Inc (RGTPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regenetp Inc (RGTPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regenetp Inc Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Chris Nolet is the director of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Chris Nolet made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net sale of 11,700 shares made by Jeetinder Singh Mahal , a net purchase of 50,000 shares made by Thomas G Wiggans , and a net purchase of 350,000 shares made by Velan Capital Master Fund Lp .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 4,397 shares of Jasper Therapeutics Inc (JSPR) were sold and 545,000 shares were bought by its insiders, resulting in a net purchase of 540,604 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

Chris Nolet Mailing Address

Above is the net worth, insider trading, and ownership report for Chris Nolet. You might contact Chris Nolet via mailing address: C/o Revance Therapeutics, Inc., 7555 Gateway Boulevard, Newark Ca 94560.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.